Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer

• Main Authors: Shengya Fu (Author), Linjuan Li (Author), Xiaofen Li (Author), Qiang Wu (Author), Xiaohui Wang (Author), Yan Huang (Author), Haoyue Hu (Author), Dan Cao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gastric cancer is the second most prevalent cancer and the second leading cause of cancer-related death in China. The prognosis of metastatic gastric cancer is poor with a median overall survival of 8-10 months. Apatinib, an oral small-molecule, selective vascular endothelial growth factor receptor-...